• Dépistage, diagnostic, pronostic

  • Politiques et programmes de dépistages

  • Col de l'utérus

Cervical cancer screening pathways in France in 2015–2021, a nationwide study based on medico-administrative data

Menée à partir de l'analyse de données médico-administratives couvrant près de 100 % de la population française, cette étude identifie les caractéristiques socio-démographiques des participantes et des non participantes au dépistage du cancer du col de l'utérus sur la période 2015-2021 puis examine le respect des recommandations concernant le délai entre deux examens de dépistage individuel ou organisé

To better document cervical cancer screening (CCS) pathways, the purpose of our study was to examine CCS pathways among women who had undergone a screening test (opportunistic or organised programme), based on real-life data over a 7-year period. This study used data from the French national health care database (SNDS), which covers almost 100 % of the French population of around 66 million inhabitants. Data from 2015 to 2021 were extracted. More than one quarter (27 %) of women who were at least 25 years old in 2015 and up to 65 years old in 2021 were not screened over the 2015–2021 period. Compared to women who had undergone screening at least once, women who were not screened were older (36 % vs. 23 % in the 50–59 years age group in 2015) and lived in the most deprived urban areas (21 % vs 16 % for less and most deprived respectively). 57 % of women underwent screening within recommended intervals, 13 % of women were under-screened, and 30 % were overscreened. Overall, our study identified that, in 2021, women who participated in the French organised screening programme were less likely to be screened within the recommended interval over the 7-year period. These analyses need to be continued over time in order to assess whether the programme helps reintegrate women into the screening process.

Preventive Medicine Reports , article en libre accès, 2023

Voir le bulletin